Welcome to Genmab
Engineering a
transformative tomorrow
As a leading international biotechnology company, we believe in the transformative power of science and technology. Science is not only our bedrock, it is our inspiration. We believe in improving the lives of patients with cancer by creating and developing innovative and differentiated antibody therapeutics that will transform the future of cancer treatment. We are Genmab.
Pipeline
Transforming the future of cancer treatment
Cancer presents constant challenges in our society—from advancing drug development to fulfilling the unmet medical needs of patients. At Genmab, we have an appreciation for the power of the human immune system that gives us a unique perspective on how to respond and find solutions. That’s why we are focused on harnessing the immune system’s natural ability to fight against diseases to create therapeutics that have the potential to transform how cancer is treated.
Our Technology Platforms
Pioneering the next generation of antibody platforms
With an in-depth knowledge of antibody biology, we discover, develop and select the best possible antibody products. This relentless drive to innovate and advance the process of antibody discovery has led to our proprietary antibody technologies.
fIRST HALF 2020 FINANCIAL RESULTS
Genmab’s First Half 2020 Financial Results
Genmab will report its financial results for the first half of 2020 after market close in Europe on August 12. An investor conference call to discuss the results will be held at 6:00 PM CEST/ 12:00 PM EDT on August 12. To join the call by phone, dial one of the following numbers and provide the confirmation code 5658476: +45 32720417 in Denmark, +1 646 741 3167 in the US or +44 2071 928338 in the UK or any other location not listed.
We turn science into medicine. We use our deep antibody expertise to create cancer therapeutics with the potential to improve patients’ lives.
Our Products
We are focused on our vision of transforming the future of cancer treatment.
Stock Information
We aim to share relevant, accurate and timely information with our investors.
Genmab News
With innovations, partnerships and presentations, we are making headlines.
Our Science
Our passion for innovation is driven by data and rooted in science.
Current Partnerships
We know the value of finding and being good partners.
Grants & Sponsorships
We are committed to advancing healthcare and improving patient outcomes.
